John T. Treace, Chief Executive Offer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 15,000 shares at $21.83 ($327K) on 2022-11-21, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |